Acorda Therapeutics
(OTC) ACOR
This security has been delisted. This page is retained for historical reference.
ACOR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowACOR Financials
Key Financial Metrics (TTM)
Gross Margin
61%
Operating Margin
-20%
Net Income Margin
-2%
Return on Equity
8%
Return on Capital
21%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$71.59M
Operating Income
$23.26M
EBITDA
$201.82M
Operating Cash Flow
$13.98M
Capital Expenditure
$264.00K
Free Cash Flow
$14.25M
Cash & ST Invst.
$30.36M
Total Debt
$190.90M
Acorda Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$20.29M
-8.8%
Gross Profit
$16.58M
-12.8%
Gross Margin
81.73%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
102
N/A
Net Income
$27.39M
-62.8%
EBITDA
$12.67M
-296.7%
Quarterly Fundamentals
Net Cash
$186.56M
-27.0%
Accounts Receivable
$9.19M
-0.0%
Inventory
$14.12M
+4.9%
Long Term Debt
$2.85M
-98.4%
Short Term Debt
$193.07M
+12308.3%
Return on Assets
-2.15%
N/A
Return on Invested Capital
21.14%
N/A
Free Cash Flow
$20.18M
-187.6%
Operating Cash Flow
$20.18M
-187.6%